Finding 44412 (2022-002)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2022
Accepted
2023-03-29

AI Summary

  • Core Issue: The Medical Center claimed more expenses than funds received for the COVID-19 Testing program, indicating a lack of effective internal controls.
  • Impacted Requirements: Compliance with 2 CFR 200.303(a) was not met, as there was insufficient review and approval of claimed expenses.
  • Recommended Follow-Up: Implement a robust control process that includes a secondary review and approval of all expenses claimed under the federal program.

Finding Text

Department of Health and Human Services Federal Assistance Listing #93.697 COVID-19 Testing and Mitigation for Rural Health Clinics Activities Allowed or Unallowed and Allowable Costs/Cost Principles Significant Deficiency in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over federal awards that provides reasonable assurance that the Medical Center is managing the federal awards in compliance with federal statutes, regulations and terms and conditions of the federal award. Condition: The Medical Center?s listing of expenses claimed under the Testing and Mitigation for Rural Health Clinics program as an allowable cost had more expenses than funds received. Some of these excess funds related to a different period and would have been reported on the Schedule in a different year. This should have been caught with an effective secondary review of expenses. Cause: The Medical Center did not have an internal control process in place to ensure the review and approval of the expenses claimed under the federal program that was detailed enough to catch certain errors. Effect: Without an effective secondary review and approval, the allowable expenses might not be accurately calculated. Questioned Costs: None noted. Context: A nonstatistical sample of 65 ($152,804) from a population of 482 items ($602,846) were tested for activities allowed or unallowed and allowable costs/cost principles. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center implement a control process which includes a secondary review and approval of the detail final expenditure listing used to claim the allowable costs under the federal program. Views of Responsible Officials: Management agrees with the finding.

Corrective Action Plan

Finding 2022-002: Activities Allowed or Unallowed and Allowable Costs/Cost Principles Federal Agency Name: Department of Health and Human Services Program Name: COVID-19 Testing and Mitigation for Rural Health Clinics Federal Financial Assistance Listing/CFDA Number: 93.697 Finding Summary: The Medical Center?s listing of expenses claimed under the Testing and Mitigation for Rural Health Clinics program as an allowable cost had more expenses than funds received. Some of these excess funds related to a different period and would have been reported on the Schedule in a different year. This should have been caught with an effective secondary review of expenses. Responsible Individuals: Nathan Pickel, Chief Financial Officer Corrective Action Plan: Management agrees with the finding. Controls will be put into place for a more thorough review of the expense detail to ensure expenditures being claimed pertain to the year in which they were incurred. For the current year, the expense detail was ran by accounting date as opposed to service date. Anticipated Completion Date: June 30, 2023

Categories

Allowable Costs / Cost Principles Significant Deficiency

Other Findings in this Audit

  • 44413 2022-003
    Material Weakness
  • 620854 2022-002
    Significant Deficiency
  • 620855 2022-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.697 Covid-19 Testing for Rural Health Clinics $600,000
93.461 Covid-19 Testing for the Uninsured $77,397
21.019 Coronavirus Relief Fund $38,259
93.074 Hospital Preparedness Program (hpp) and Public Health Emergency Preparedness (phep) Aligned Cooperative Agreements $12,814
93.268 Immunization Cooperative Agreements $6,990
93.889 National Bioterrorism Hospital Preparedness Program $6,419
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $2,418